Supernus Pharmaceuticals SUPN Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $186.32M+43.4% | $129.9M-15.0% | $152.82M+5.6% | $144.71M+24.9% | $115.85M+67.1% | ||
| $1.45M0.0% | $1.45M0.0% | $1.45M— | —— | $0— | ||
| $182.18M-3.0% | $187.8M+9.7% | $171.25M+21.6% | $140.83M-3.3% | $145.64M+2.5% | ||
| $23.71M-21.2% | $30.1M+8.6% | $27.7M-37.1% | $44.02M-10.9% | $49.42M— | ||
| $36.05M+22.5% | $29.44M-11.9% | $33.41M+113% | $15.65M-16.3% | $18.69M-30.1% | ||
| $19.54M-7.5% | $21.12M+26.4% | $16.71M-16.3% | $19.95M-9.6% | $22.07M+34.2% | ||
| $78.09M+19.5% | $65.33M+5.2% | $62.08M+97.6% | $31.42M+8.6% | $28.93M-19.8% | ||
| $731.58M+13.6% | $644.18M+8.5% | $593.89M-19.6% | $738.87M+7.5% | $687.58M+0.2% | ||
| $10.04M-4.6% | $10.53M-0.9% | $10.63M-4.0% | $11.07M-2.4% | $11.34M-1.8% | ||
| $18.75M+2.7% | $18.26M-6.1% | $19.46M+2.5% | $18.98M+2.9% | $18.44M+3.3% | ||
| —— | —— | —— | —— | —— | ||
| $120.67M-3.4% | $124.88M+4.9% | $119.08M+1.8% | $117.02M0.0% | $117.02M0.0% | ||
| $549.71M-3.5% | $569.46M-8.7% | $623.48M+29.5% | $481.31M-4.1% | $502.13M-3.8% | ||
| $30.82M-19.6% | $38.35M— | $0— | $0-100% | $981K-80.2% | ||
| $676K-4.1% | $705K-98.9% | $62.43M+123% | $27.96M-4.3% | $29.22M-7.3% | ||
| $199.37M+10.6% | $180.22M+38.9% | $129.79M-65.7% | $377.89M+8.7% | $347.74M-9.5% | ||
| $1.5B+3.3% | $1.45B+2.3% | $1.42B+2.7% | $1.38B+2.6% | $1.35B-1.5% | ||
| $24.21M-17.8% | $29.45M-16.6% | $35.3M+72.5% | $20.46M+16.3% | $17.6M— | ||
| $10.64M+0.2% | $10.61M-1.6% | $10.79M+46.0% | $7.39M+24.5% | $5.94M-13.8% | ||
| $373.93M+10.6% | $338.17M+2.3% | $330.63M+15.5% | $286.36M+1.6% | $281.77M-3.6% | ||
| $30.27M-0.3% | $30.37M-3.4% | $31.42M+28.9% | $24.38M-7.5% | $26.37M-3.7% | ||
| $40.9M-0.2% | $40.98M-2.9% | $42.21M+32.9% | $31.77M-1.6% | $32.31M-5.7% | ||
| $19.52M-12.0% | $22.19M+184% | $7.82M+0.8% | $7.76M+4.0% | $7.46M-1.8% | ||
| $206K-99.3% | $31.26M-91.6% | $370.09M+16.2% | $318.51M+0.6% | $316.59M-4.7% | ||
| 130M0.0% | 130M0.0% | 130M0.0% | 130M0.0% | 130M+232,043% | ||
| $561.42M+3.2% | $543.83M+3.1% | $527.7M+6.2% | $496.95M+2.2% | $486.21M+1.4% | ||
| $515.58M-0.4% | $517.88M-0.8% | $521.98M-8.0% | $567.1M+4.1% | $544.6M-2.1% | ||
| -$255K-480% | -$44K+38.0% | -$71K+64.5% | -$200K-25.8% | -$159K+15.9% | ||
| $1.08B+1.4% | $1.06B+1.1% | $1.05B-1.3% | $1.06B+3.2% | $1.03B-0.5% | ||
| $1.5B+3.3% | $1.45B+2.3% | $1.42B+2.7% | $1.38B+2.6% | $1.35B-1.5% | ||
| $199.37M+10.6% | $180.22M+38.9% | $129.79M-65.7% | $377.89M+8.7% | $347.74M-9.5% | ||
| $199.37M+10.6% | $180.22M+38.9% | $129.79M-65.7% | $377.89M+8.7% | $347.74M-9.5% | ||
| $1.9M+5.6% | $1.8M-71.4% | $6.3M+16.7% | $5.4M— | —— | ||
| $87.06M+5.7% | $82.39M+3.8% | $79.4M— | —— | —— | ||
| $19.54M-7.5% | $21.12M+26.4% | $16.71M-16.3% | $19.95M-9.6% | $22.07M+34.2% | ||
| $56.45M-11.5% | $63.8M+2.2% | $62.43M+123% | $27.96M-4.3% | $29.22M-7.3% | ||
| $26.4M-1.2% | $26.71M-7.1% | $28.76M+31.4% | $21.88M-3.7% | $22.72M-7.2% | ||
| $30.82M-19.6% | $38.35M+336% | $8.79M+42.3% | $6.18M— | —— | ||
| $676K-4.1% | $705K— | —— | —— | —— | ||
| $549.71M-3.5% | $569.46M-8.7% | $623.48M+29.5% | $481.31M-4.1% | $502.13M-3.8% | ||
| $26.4M-1.2% | $26.71M-7.1% | $28.76M+31.4% | $21.88M-3.7% | $22.72M-7.2% | ||
| $56.45M-11.5% | $63.8M+2.2% | $62.43M+123% | $27.96M-4.3% | $29.22M-7.3% | ||
| $28.8M0.0% | $28.8M-4.3% | $30.09M+0.1% | $30.05M+0.9% | $29.78M+1.3% | ||
| $26.4M-1.2% | $26.71M-7.1% | $28.76M+31.4% | $21.88M-3.7% | $22.72M-7.2% | ||
| $56.45M-11.5% | $63.8M+2.2% | $62.43M+123% | $27.96M-4.3% | $29.22M-7.3% | ||
| $24.21M-17.8% | $29.45M-16.6% | $35.3M+72.5% | $20.46M+16.3% | $17.6M-17.1% | ||
| $1.63M-32.1% | $2.4M-37.9% | $3.87M-24.6% | $5.13M-18.0% | $6.25M-22.9% | ||
| $101.24M-6.1% | $107.8M-0.7% | $108.61M+39.7% | $77.74M+1.1% | $76.89M+0.7% | ||
| $101.24M-6.1% | $107.8M-0.7% | $108.61M+39.7% | $77.74M+1.1% | $76.89M+0.7% | ||
| $101.24M-6.1% | $107.8M-0.7% | $108.61M+39.7% | $77.74M+1.1% | $76.89M+0.7% | ||
| $189.72M+17.8% | $161.1M-12.7% | $184.46M+2.0% | $180.92M+6.3% | $170.13M+0.8% | ||
| $24.21M-17.8% | $29.45M-16.6% | $35.3M+72.5% | $20.46M+16.3% | $17.6M-17.1% | ||
| $82.97M+117% | $38.22M+45.2% | $26.32M-5.0% | $27.71M+484% | $4.75M— | ||
| $16.12M-3.2% | $16.67M+12.3% | $14.84M-7.0% | $15.96M+7.6% | $14.83M+34.8% | ||
| $206K0.0% | $206K-3.3% | $213K— | $0-100% | $30M— | ||
| $40.9M-0.2% | $40.98M-2.9% | $42.21M+32.9% | $31.77M-1.6% | $32.31M-5.7% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 58M+1.0% | 57.5M+0.6% | 57.1M+1.8% | 56.1M+0.2% | 56M+0.4% | ||
| $58K+1.8% | $57K0.0% | $57K+1.8% | $56K0.0% | $56K0.0% | ||
| 4.1M+13.5% | 3.6M-5.7% | 3.9M-19.6% | 4.8M-1.9% | 4.9M+18.3% | ||
| 6.8M+6.8% | 6.3M-2.7% | 6.5M-13.4% | 7.5M-1.6% | 7.6M+13.8% | ||
| 6.8M+6.8% | 6.3M-2.7% | 6.5M-13.4% | 7.5M-1.6% | 7.6M+13.8% | ||
| $1K-97.1% | $34K+467% | $6K-62.5% | $16K+33.3% | $12K-86.5% | ||
| $254K+841% | $27K-41.3% | $46K-78.9% | $218K+26.0% | $173K-40.1% | ||
| $35.04+7.4% | $32.63+1.5% | $32.15+3.6% | $31.04+0.1% | $31.01+1.9% | ||
| $35.04+7.4% | $32.63+1.5% | $32.15+3.6% | $31.04+0.1% | $31.01+1.9% | ||
| $31.47M-1.1% | $31.83M-44.1% | $56.99M— | —— | —— | ||
| $28.8M0.0% | $28.8M-4.3% | $30.09M+0.1% | $30.05M+0.9% | $29.78M+1.3% | ||
| $206K-99.3% | $31.26M+173% | $11.45M— | $0-100% | $30M-36.6% | ||
| $20.69M-19.2% | $25.61M+95.5% | $13.1M+64.7% | $7.95M-28.1% | $11.07M-5.0% | ||
| $37.23M-1.5% | $37.8M-12.6% | $43.27M-6.0% | $46.02M-7.8% | $49.93M-6.5% | ||
| $16.12M-3.2% | $16.67M+12.3% | $14.84M-7.0% | $15.96M+7.6% | $14.83M+34.8% | ||
| $152.5M+23.7% | $123.3M-12.7% | $141.19M+4.7% | $134.89M+12.2% | $120.21M+4.2% | ||
| $3.77M-48.3% | $7.3M-19.9% | $9.11M+177% | $3.29M-39.2% | $5.41M-8.2% | ||
| $1.63M-32.1% | $2.4M-37.9% | $3.87M-24.6% | $5.13M-18.0% | $6.25M-22.9% | ||
| $254K+841% | $27K-41.3% | $46K-78.9% | $218K+26.0% | $173K-40.1% | ||
| $1K-97.1% | $34K+467% | $6K-62.5% | $16K+33.3% | $12K-86.5% | ||
| $206K-99.3% | $31.26M+173% | $11.45M— | $0-100% | $30M-36.6% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $130M0.0% | $130M0.0% | $130M0.0% | $130M0.0% | $130M0.0% | ||
| $58.04M+1.0% | $57.46M+0.6% | $57.12M+1.8% | $56.12M+0.2% | $55.99M+0.4% | ||
| $58.04M+1.0% | $57.46M+0.6% | $57.12M+1.8% | $56.12M+0.2% | $55.99M+0.4% | ||
| $199.63M+10.8% | $180.22M+38.8% | $129.83M-65.7% | $378.09M+8.7% | $347.9M-9.5% | ||
| $199.37M+10.6% | $180.22M+38.9% | $129.79M-65.7% | $377.89M+8.7% | $347.74M-9.5% | ||
| $31.47M-1.1% | $31.83M-44.1% | $56.99M— | —— | —— | ||
| $14.01M+7.0% | $13.09M-2.6% | $13.44M+43.9% | $9.34M+7.0% | $8.72M+24.8% | ||
| $35.04+7.4% | $32.63+1.5% | $32.15+3.6% | $31.04+0.1% | $31.01+1.9% | ||
| $4.13M+13.5% | $3.64M-5.7% | $3.86M-19.6% | $4.8M-1.9% | $4.89M+18.3% | ||
| $6.77M+6.8% | $6.34M-2.7% | $6.52M-13.4% | $7.53M-1.6% | $7.65M+13.8% | ||
| $6.77M+6.8% | $6.34M-2.7% | $6.52M-13.4% | $7.53M-1.6% | $7.65M+13.8% | ||
| $35.04+7.4% | $32.63+1.5% | $32.15+3.6% | $31.04+0.1% | $31.01+1.9% | ||
| $32.44+1.1% | $32.08+1.0% | $31.76+5.3% | $30.16+0.1% | $30.13+2.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Supernus Pharmaceuticals cover its short-term obligations?
- Its current ratio is 1.96 — current assets exceed current liabilities.
- Where does Supernus Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Supernus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.